Sutinib Capsule
SUTINIB, an oral multi-kinase inhibitor, is the malate salt of sunitinib. Sunitinib is a type of treatment called a multi-kinase inhibitor.
Description
Kinases are important proteins in the body that regulate how the cells grow and divide. Sunitinib works by blocking (inhibiting) signals within the cancer cells that make them grow and divide. Blocking the signals causes the cells to die. Sunitinib can also stop cancer cells from developing new blood vessels. This reduces their supply of oxygen and nutrients, which causes the tumour to shrink or stop growing. Drugs that interfere with blood vessel growth in this way are called angiogenesis inhibitors or anti-angiogenics.
Indications And Usage :
- Gastrointestinal Stromal Tumor
- Advanced Renal Cell Carcinoma
- Advanced Pancreatic Neuroendocrine Tumors
Dosage And Administration :
- Recommended Dose for GIST and RCC
- The recommended dose of SUTINIB for gastrointestinal stromal tumor (GIST) and advanced renal cell carcinoma (RCC) is one 50 mg oral dose taken once daily.
- Recommended Dose for pNET
- The recommended dose of SUTINIB for pancreatic neuroendocrine tumors (pNET) is 25 mg taken orally once daily continuously without a scheduled off-treatment period. SUTINIB may be taken with or without food.
Features:
- Accurate composition
- Longer shelf life
- Precisely processed
